Abeona Therapeutics (ABEO) Profit After Tax (2011 - 2026)

Abeona Therapeutics' Profit After Tax history runs 16 years deep, the most recent figure standing at -$17.1 million for Q1 2026.

• In Q1 2026, Profit After Tax fell 41.95% year-over-year to -$17.1 million; the TTM figure through Mar 2026 stood at $66.1 million (up 249.68% YoY), while the FY2025 annual figure was $71.2 million, up 211.69% from the prior year.
• Profit After Tax was -$17.1 million for Q1 2026 at Abeona Therapeutics, up from -$20.5 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $108.8 million in Q2 2025 to a low of -$31.6 million in Q1 2024.
• Historically, Profit After Tax has averaged -$6.1 million across 5 years, with a median of -$11.8 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Profit After Tax sank 306.49% in 2023, then soared 1369.52% in 2025.
• A 5-year view of Profit After Tax shows it stood at -$7.1 million in 2022, then tumbled by 132.99% to -$16.6 million in 2023, then soared by 43.99% to -$9.3 million in 2024, then slumped by 120.17% to -$20.5 million in 2025, then grew by 16.54% to -$17.1 million in 2026.
• The last three Profit After Tax figures came in at -$17.1 million (Q1 2026), -$20.5 million (Q4 2025), and -$5.2 million (Q3 2025), per Business Quant data.